Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q1057705> ?p ?o }
Showing triples 1 to 37 of
37
with 100 triples per page.
- Q1057705 subject Q7116685.
- Q1057705 subject Q8573019.
- Q1057705 abstract "Cethromycin, trade name Restanza (initially known as ABT-773) is a ketolide antibiotic undergoing research for the treatment of community acquired pneumonia (CAP) and for the prevention of post-exposure inhalational anthrax, and was given an "orphan drug" status for this indication. Originally discovered and developed by Abbott, it was acquired by Advanced Life Sciences Inc. for further development.On October 1, 2008 Advanced Life Sciences submitted a New Drug Application (NDA) to Food and Drug Administration (FDA) for cethromycin to treat mild-to-moderate community acquired pneumonia.On December 3, 2008 Advanced Life Sciences announced that this New Drug Application has been accepted for filing by the FDA.In June 2009, the an FDA Anti-Infective Drugs Advisory Committee review found insufficient evidence for cethromycin efficacy in treatment of community acquired pneumonia, as the Phase 3 clinical trial followed standards that were updated after the clinical trial but three months prior to review. The committee did, however, find the drug safe to use.".
- Q1057705 atcPrefix "none".
- Q1057705 bioavailability "60.0".
- Q1057705 casNumber "205110-48-1".
- Q1057705 fdaUniiCode "J0086219X6".
- Q1057705 iupacName "(1S,2R,5R,7R,8R,9S,11R,13R,14R)-8-[(2S,3R,4S,6R)- 4-Dimethylamino-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-1,5,7,9,11,13- hexamethyl-9-[(E)-3-quinolin-3-ylprop-2-enoxy]-3,17-dioxa-15-azabicyclo[12.3.0]heptadecane-4,6,12,16-tetrone".
- Q1057705 pubchem "5282045".
- Q1057705 thumbnail Cethromycin.png?width=300.
- Q1057705 wikiPageExternalLink 1096.
- Q1057705 wikiPageWikiLink Q12187.
- Q1057705 wikiPageWikiLink Q129104.
- Q1057705 wikiPageWikiLink Q1367466.
- Q1057705 wikiPageWikiLink Q1368197.
- Q1057705 wikiPageWikiLink Q1445686.
- Q1057705 wikiPageWikiLink Q204711.
- Q1057705 wikiPageWikiLink Q30612.
- Q1057705 wikiPageWikiLink Q306764.
- Q1057705 wikiPageWikiLink Q460030.
- Q1057705 wikiPageWikiLink Q7116685.
- Q1057705 wikiPageWikiLink Q8573019.
- Q1057705 wikiPageWikiLink Q9368.
- Q1057705 atcPrefix "none".
- Q1057705 bioavailability "Between 35.8 and 60 % in animal studies.".
- Q1057705 casNumber "205110".
- Q1057705 iupacName "-8".
- Q1057705 pubchem "5282045".
- Q1057705 unii "J0086219X6".
- Q1057705 type ChemicalSubstance.
- Q1057705 type Drug.
- Q1057705 type ChemicalObject.
- Q1057705 type Thing.
- Q1057705 type Q8386.
- Q1057705 comment "Cethromycin, trade name Restanza (initially known as ABT-773) is a ketolide antibiotic undergoing research for the treatment of community acquired pneumonia (CAP) and for the prevention of post-exposure inhalational anthrax, and was given an "orphan drug" status for this indication. Originally discovered and developed by Abbott, it was acquired by Advanced Life Sciences Inc.".
- Q1057705 label "Cethromycin".
- Q1057705 depiction Cethromycin.png.